A Double-blind, Placebo-controlled, Parallel-group Comparison of Venlafaxine Extended-release Capsules and Paroxetine in Outpatients With Panic Disorder

Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 653 人开始时间: 2001年11月1日最近更新: 2009年8月14日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方
入组人数: 653

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

The primary objective is to determine the efficacy, safety, and tolerability of venlafaxine extended release (ER) capsules in the treatment of outpatients with panic disorder (PD) in comparison to those of placebo.

研究设计

研究类型: Interventional
主要目的: Treatment

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Meet DSM-IV criteria for PD (with or without agoraphobia) for at least 3 months before study day 1
•Have sufficient symptoms to require anxiolytic drug therapy
•Have a score ≥4 on the Clinical Global Impressions Scale (CGI) severity of illness item at screening and baseline

排除标准

•Known hypersensitivity to venlafaxine (IR or ER), related compounds, or paroxetine
•History or presence of any clinically important hepatic, renal, or other medical disease that might compromise the study or be detrimental to the patient (eg, clinically important cardiac arrhythmia, unstable diabetes, carcinoma [except basal cell epithelioma], uncontrolled hypertension)
•Clinically important abnormality on screening physical examination, vital signs, electrocardiogram (ECG), laboratory tests or urine drug screen

研究者

发起方

Wyeth is now a wholly owned subsidiary of Pfizer

申办方类型

Industry

相似试验

已完成

2 期

Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in AdultsMajor Depressive Disorder

NCT00839423H. Lundbeck A/S426

已完成

3 期

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety DisorderSocial Anxiety Disorder

NCT00238719Wyeth is now a wholly owned subsidiary of Pfizer293

已完成

3 期

Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive DisorderMajor Depressive Disorder

NCT00887224Pfizer874

已完成

4 期

Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious PatientsAnxiety DisordersDepression

NCT00546923Wyeth is now a wholly owned subsidiary of Pfizer210

已完成

3 期

Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal WomenVasomotor Symptoms

NCT00683800Pfizer2,186